Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microbial Interactions: Cooperation01:26

Microbial Interactions: Cooperation

Microbial cooperation involves beneficial interactions in which different species work together for individual or mutual advantage. These interactions can profoundly influence ecological dynamics and evolutionary processes, and they are essential to many pathogenic and symbiotic relationships.Nematode–Bacteria CooperationA striking example is the relationship between the Gram-negative bacterium Xenorhabdus nematophila and the parasitic nematode Steinernema carpocapsae. Juvenile nematodes...
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microbial Interactions: Mutualism01:25

Microbial Interactions: Mutualism

Mutualism is a symbiotic interaction in which all participating organisms benefit. These relationships can be obligate or facultative and are fundamental to ecosystem functions across diverse biological systems.Plant–Fungi MutualismOne well-known example is the association between plant roots and mycorrhizal fungi, such as Rhizophagus species. The fungal hyphae penetrate the root hairs and the epidermis, forming an extensive hyphal network that establishes a symbiotic association. Through this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroretinal Layer Thinning on OCT Imaging and Hemoglobin A1c in Youth With Type 1 Diabetes.

JAMA ophthalmology·2026
Same author

Automated Insulin Delivery Use Among Preschool-Age Children With Type 1 Diabetes: A T1D Exchange Multicenter Analysis.

Journal of diabetes science and technology·2026
Same author

Bile Salts and Bacterial Bile Salt Hydrolase Activity Influence Escherichia coli Colonization and FXR Signaling in Colorectal Cancer Organoids.

Annals of biomedical engineering·2026
Same author

Outpatient Management of Slipped Capital Femoral Epiphysis Is Common, Safe, and Saves Costs: A Single-Institution Analysis and Results From a National Database Survey.

The Journal of the American Academy of Orthopaedic Surgeons·2026
Same author

Factors Associated With Time to Automated Insulin Delivery System Initiation in Youth With Type 1 Diabetes.

Journal of diabetes science and technology·2026
Same author

Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression.

Cancer research·2026

Related Experiment Video

Updated: Jul 10, 2026

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface
10:24

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface

Published on: July 4, 2018

Engineering commensal microbes for host health.

Elizabeth A Brown1, Arianna Brevi1, David M Zong1

  • 1Division of Gastroenterology, University of California, San Diego, La Jolla, CA, USA.

Cell Host & Microbe
|July 8, 2026
PubMed
Summary

Engineered live biotherapeutic products (eLBPs) are programmable microbes for disease treatment. This review covers eLBP progress, design factors, and challenges for future clinical translation.

Keywords:
CRISPR-associated transposasesEngraftmentEscherichia coli Nissle 1917Quorum sensingauxotrophycalprotectincurli fibershorizontal gene transferkill switchesmemory circuitsmucosal deliveryporphyrin

More Related Videos

Compost Microcosms as Microbially Diverse, Natural-like Environments for Microbiome Research in Caenorhabditis elegans
07:19

Compost Microcosms as Microbially Diverse, Natural-like Environments for Microbiome Research in Caenorhabditis elegans

Published on: September 13, 2022

Isolation and Characterization of the Natural Microbiota of the Model Nematode Caenorhabditis elegans
07:05

Isolation and Characterization of the Natural Microbiota of the Model Nematode Caenorhabditis elegans

Published on: August 17, 2022

Related Experiment Videos

Last Updated: Jul 10, 2026

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface
10:24

Assessing the Viability of a Synthetic Bacterial Consortium on the In Vitro Gut Host-microbe Interface

Published on: July 4, 2018

Compost Microcosms as Microbially Diverse, Natural-like Environments for Microbiome Research in Caenorhabditis elegans
07:19

Compost Microcosms as Microbially Diverse, Natural-like Environments for Microbiome Research in Caenorhabditis elegans

Published on: September 13, 2022

Isolation and Characterization of the Natural Microbiota of the Model Nematode Caenorhabditis elegans
07:05

Isolation and Characterization of the Natural Microbiota of the Model Nematode Caenorhabditis elegans

Published on: August 17, 2022

Area of Science:

  • Microbiology
  • Synthetic Biology
  • Biotechnology

Background:

  • Engineered live biotherapeutic products (eLBPs) are programmable microbial therapies.
  • Advances in microbiome science and synthetic biology enable engineered bacteria for therapeutic applications.

Purpose of the Study:

  • To review recent progress in eLBP development for various diseases.
  • To highlight key design factors and challenges for eLBP translation.

Main Methods:

  • Review of current literature on eLBP design and applications.
  • Analysis of chassis selection, DNA delivery, therapeutic expression, and biocontainment strategies.
  • Examination of clinical study outcomes and in vivo performance.

Main Results:

  • eLBPs show promise across inflammatory diseases, metabolic disorders, cancer, and infectious diseases.
  • Successful eLBP design requires careful consideration of chassis, delivery, expression, and containment.
  • Early clinical trials indicate favorable safety profiles for eLBPs.

Conclusions:

  • Challenges in predictable colonization, durable activity, and biocontainment need addressing.
  • A framework for rational design is proposed to advance next-generation eLBPs.
  • Further research is needed to reliably translate eLBPs from experimental systems to clinical practice.